HORIZON PHARMACEUTICAL LLC 8-K 2014
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2014
RAPTOR PHARMACEUTICAL CORP.
(Exact name of registrant as specified in its charter)
7 Hamilton Landing, Suite 100
Novato, California 94949
(Address of principal executive offices, including Zip Code)
Registrants telephone number, including area code: (415) 408-6200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
As previously disclosed, on July 1, 2014, Raptor Pharmaceutical Corp. (the Company) entered into an amended and restated loan agreement (the Amended and Restated Loan Agreement) with HealthCare Royalty Partners II, L.P., as lender (the Lender), which revises the terms of the loan agreement, dated as of December 20, 2012, between the Company and the Lender.
A copy of the Amended and Restated Loan Agreement is filed herewith as Exhibit 10.1. Certain information has been omitted from the Amended and Restated Loan Agreement pursuant to a request for confidential treatment filed with the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.